Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
Titel:
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
Auteur:
Ben-Ami, E. Barysauskas, C.M. von Mehren, M. Heinrich, M.C. Corless, C.L. Butrynski, J.E. Morgan, J.A. Wagner, A.J. Choy, E. Yap, J.T. Van den Abbeele, A.D. Solomon, S.M. Fletcher, J.A. Demetri, G.D. George, S.